Growth Hormone Deficiency in Patients with Chronic Heart Failure

[IMT staff]

Conclusions
The recent demonstration that deficiencies of the main anabolic forces, including the somatotropic system, worsen the prognosis of CHF patients and the current evidence for a clinical benefit of GH replacement therapy should prompt larger, multicenter trials with a placebo-controlled design aimed at evaluating the clinical and prognostic advantage of the potentiation of the main anabolic axes, in particular of the GH/IGF-I system.

In conclusion, this study demonstrates that GH deficiency is a common finding in CHF and that GH replacement therapy improves quality of life, exercise performance, and LV architecture and function.

Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction

I don't think the rest of the data for the full 4 years but its no secret what it will say.

Long-Term Effect and Efficacy of Growth Hormone Replacement Therapy in Chronic Heart Failure - Full Text View - ClinicalTrials.gov